Features
The CDTI and the Eureka program are launching their international call for proposals, the Eureka Biotech Call 2026, an initiative aimed at promoting international collaborative R&D projects focused on developing innovative solutions in the field of biotechnology.
Seventeen countries and regions are participating in the call for proposals: Austria, Belgium (Flanders and Wallonia), Canada, Chile, Estonia, France, Germany, Lithuania, the Netherlands, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, and Turkey.
This call for proposals represents an excellent opportunity to promote international collaborative projects with a clear market focus and high potential for industrial implementation in the biotechnology sector. Proposals may address a wide range of research and innovation areas related to:
- Advanced Biomanufacturing and Enabling Technologies for Biotechnology Ecosystems
- Next-Generation Therapies and Treatments
- Agricultural and Veterinary Innovations
- Advanced Diagnostics and Data-Driven Technologies
- Bioinformatics, Artificial Intelligence, and Digitalization Applied to Biotechnology
- Bioprocess Technologies and Sustainable Bioindustrial Solutions
Application areas include, among others:
- Health and Medicine
- Pharmaceuticals and Advanced Therapies
- Industrial Biotechnology
- Agriculture and Food
- Diagnostics and Medical Devices
- Bioeconomy and Sustainability
- Digital Health and Biological Data Analysis
The call for proposals will feature activities and international networking tools to facilitate the identification of partners and the formation of collaborative consortia among companies, startups, universities, and technology centers interested in developing joint projects.
Requirements:
This call for proposals is aimed at market-oriented R&D projects involving experimental development activities and with technology readiness levels primarily ranging from TRL 5 to TRL 7. The participation of at least two independent entities from two different participating countries will be required, with companies playing a significant role within the international consortia.
The minimum budget for each company is €175,000. There is no budget limit for Spanish partners, but the budget must be commensurate with the activities to be carried out and the company’s capacity.
The Spanish company (or the Spanish consortium coordinator, where applicable) must submit a formal application for funding for the international R&D project through the CDTI’s online portal by October 2, 2026. The application must include the Eureka Application Form (in English) and, when available, a draft of the consortium agreement. The signed consortium agreement must be submitted before the Eureka label is granted.
Once the international application has been received, CDTI will verify the eligibility of the Spanish applicants. If they are deemed eligible, CDTI will process the corresponding national funding applications for each Spanish participant. These applications must be completed and duly submitted by all Spanish partners within the deadline set by CDTI, approximately one month after the call’s deadline.
Depending on the funding instrument requested, CDTI may require the submission of additional documentation in Spanish. Spanish partners who do not submit the required applications by the established deadlines may be excluded.
Funding for startups, SMEs, and large companies covers up to 85% of the project’s eligible costs.
IBSAL (a research center) and universities are participating as subcontractors in the project.
How to apply
The deadline for submitting applications is September 25, 2026, at 11:59 p.m. CEST.
Project start date: second quarter of 2027
You can find all the information about the objectives, eligibility requirements, application process, and funding for this call at the following link: Eureka Biotech Call 2026.